PATENT CLAIM ANALYSIS

Application Number: 15742702
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["435", "006140"]

Abstract:
The use of PHGDH as a biomarker for detecting the occurrence of epithelial-to-mesenchymal transition (EMT) in a subject, and the use of PHGDH modulators to treat cancer is disclosed herein. Also disclosed are various methods for detecting the occurrence of epithelial-to-mesenchymal transition (EMT) in a subject by measuring PHGDH expression and/or activity.

Claim (Index 64):
A method according to  claim 62  or  claim 63 , wherein the animal model is not a human.

Metadata:
- Claim Count in Document: 71.0
- Percentile: 86.0
- Lexical Diversity: 1.59459
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14398572', '12742546', '14690001', '13320060', '15533049']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6316896955666557
- 35 USC 102 Novelty (BERT): 0.5298189199922697
- Combined Prediction Score: 0.6215026180092171
- Mean Citation Score: 257.888148
- Max Citation Score: 317.90555
- Similarity Product: 138.91597312136443

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test